Related Experiment Video
Updated: Jun 4, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Hyperglycaemia in preterm neonates: what to know, what to do
Marcelo H Decaro1, Nestor E Vain
1FUNDASAMIN, Buenos Aires, Argentina.
Abstract:
Neonatal hyperglycaemia is a frequent complication in VLBW infants during the first week of life. The more common causes include high glucose intake, stress situations such as sepsis, NEC, and surgical treatments, as well as the administration of vasoactive drugs and methylxanthines. The appropriate definition is unclear. Hyperglycaemia has been associated with increased mortality and major morbidities. There have been insufficient randomized clinical trials to help in clarifying which infants should be treated, and there are insufficient data on the pharmacokinetics of insulin in these vulnerable patients.
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes Mellitus: Type 2 and Gestational
Hypoglycemia
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hyperglycemia
Diabetes: Symptoms, Diagnosis, and Complications

